Bortenet Bortezomib injection

Name: Bortenet Bortezomib injection
Brand: Maheshwari Medical Agency
Price: 1600 INR
Availability: InStock

Price 1600 INR/ Pack

Get a Price/Quote

MOQ : 3 Packs

Bortenet Bortezomib injection Specification

Origin
India

Dosage Form
Injection

Indication
Multiple myeloma and mantle cell lymphoma

Salt Composition
Bortezomib

Enzyme Types
Proteasome inhibitor

Feature
Single-dose vial, for intravenous or subcutaneous use

Ingredients
Other

Application
Other

Physical Color/Texture
White to off-white lyophilized powder

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits 26S proteasome

Storage Instructions
Below 25c

Shelf Life
2 years

Usage Precaution
To be administered by healthcare professionals only

Prescription Status
Prescription only medicine

Solvent For Dilution
Sterile 0.9% Sodium Chloride solution

Administration Route
Intravenous or subcutaneous injection only

Strength
2 mg/vial or 3.5 mg/vial

Packaging Type
Single vial in a box with leaflet

Contraindications
Hypersensitivity to Bortezomib or boron-containing compounds

Bortenet Bortezomib injection Trade Information

Minimum Order Quantity
3 Packs

Supply Ability
100 Packs Per Week

Delivery Time
7 Days

About Bortenet Bortezomib injection

Bortenet Bortezomib injection is a popular, prescription-only therapy from India, renowned for its exceptional effectiveness in treating multiple myeloma and mantle cell lymphoma. Available in 2 mg or 3.5 mg single-dose vials, each comes in a lavishly packaged box with a detailed leaflet. Its gorgeous white to off-white lyophilized powder is odorless, reflecting its purity. Administered intravenously or subcutaneously by healthcare professionals, this proteasome inhibitor receives favorable reviews for its controlled enzymatic activity, rigorous packaging, and extended two-year shelf life. Markdown for excellent value, trusted by leading distributors and suppliers.

Exceptional Features and Application Scope

Bortenet Bortezomib injection features a single-dose vial, utilizing a robust, sterile 0.9% sodium chloride solvent for dilution. Tailored for intravenous or subcutaneous injection, its scope is focused on combating multiple myeloma and mantle cell lymphoma. The lavishly designed packaging ensures product safety, while the surface of application is strictly limited to clinical environments, handled exclusively by certified healthcare professionals. Its white to off-white powder guarantees exceptional purity and efficacy for the intended therapeutic use.

Impressive Supply Chain, Certification, and Markets

Bortenet Bortezomib injection is handed over promptly to distributors and traders, ensuring smooth and timely deliveries. With a steady supply ability, it is delivered throughout leading export markets including Asia and Europe. Each batch is accompanied by essential certifications, validating its origin and quality. The product is securely freighted under recommended storage conditions, maintaining integrity during transport and arrival at international destinations. Reliability and compliance are at the forefront of every shipment.

FAQ's of Bortenet Bortezomib injection:

Q: How should Bortenet Bortezomib injection be administered for optimal results?

A: Bortenet Bortezomib injection should be administered only by healthcare professionals, either intravenously or subcutaneously, after proper dilution with sterile 0.9% sodium chloride solution.

Q: What are the primary indications for using Bortenet Bortezomib injection?

A: This injection is specifically indicated for the treatment of multiple myeloma and mantle cell lymphoma, targets where it exhibits notable proteasome inhibition.

Q: When should Bortenet Bortezomib injection not be used?

A: Bortenet Bortezomib injection should not be used in individuals with hypersensitivity to Bortezomib or other boron-containing compounds due to contraindication risks.

Q: Where is Bortenet Bortezomib injection primarily supplied and distributed?

A: Bortenet Bortezomib is primarily supplied and distributed throughout India and leading export markets, with deliveries managed by reputable distributors and traders.

Q: What benefits does Bortenet Bortezomib injection offer in clinical practice?

A: The injection is favored for its exceptional efficacy, favorable safety profile, and convenient single-dose vial, making it a preferred option in oncology settings for eligible patients.